No Data
No Data
Veritas In Silico --- In the second quarter, drug discovery research with each partner in the mRNA-targeting small molecule drug discovery business is progressing smoothly.
Veritas In Silico <130A> announced its financial results for the second quarter of the fiscal year ending December 2024 (January to June 2024), with business revenue of 11.5 billion yen, operating loss of 6.6 billion yen, ordinary loss of 8.8 billion yen, and net loss of 9.0 billion yen. As we didn't prepare the quarterly financial statements for the interim period ended December 2023, we didn't describe the year-over-year changes for the interim period ending December 2024. In the mRNA targeted small molecule drug discovery business, we are engaged in drug discovery.
Stock blogger Sanasae: Trump? National policy? A collection of stocks to look forward to with strong themes and good earnings [FISCO Social Reporter]
The following is a comment written by the individual investor 'Sanasae' (blog: '[Sanasae's Beautiful Investment Life]') who is a FISCO social reporter.
Part 2 of the previous day's moving stocks: Zidat, Libertas, WASH house, etc.
Stock Name <Code> 24 closing price ⇒ Compared to the previous day, FIG <4392> 317 -27 announces the issuance of CB and subscription rights. Is it more advantageous for credit buying to sell by closing the hand of M&A Souken <9552> 3395 -235? Unichika <3103> 292 -1623 is dominant in selling with a strong movement on the 23rd. Matsukiyo Kokokara & Company <3088> 2327 -134.5 yen higher, selling is dominant as inbound related. Isuzu automobiles <7202> 2095 -120.5.
Stocks that moved the day before part 2, including heavy industries such as Daiwa Heavy Industries, JTOWER, and IG Port, etc.
<コード>Stock name closing price on the 23rd ⇒ compared to the previous day Welcia HD <3141> 1984 -55.5 was also significantly higher on the 22nd due to cooperation with Amazon Japan. ROHM <6963> 2150.5 -53.5 sold out due to slow semiconductor-related returns without any particular materials. Hokkaido Electric Power <9509> 1074.5-3623 saw sales gather in the electric power sector. GS Yuasa Corporation <6674> 2746-37 Citigroup Securities downgraded investment decisions
Emerging Markets Digest: JTOWER surges, Pictsta hits maximum limit.
<5585> Econavi Star 1864 rose 26% in response. It was announced that the service 'Lifestyle Navi + Dr.' based on sleep analysis technology, which is a top runner in SaaS-type monitoring system for elderly facilities, was introduced for the first time in medical institutions. 'Lifestyle Navi + Dr.' utilizes AI developed by the company to analyze big data such as the sleep and vital data of hospitalized patients, and provides real-time analysis via the cloud. It has been introduced in 20 beds of the Shinritsu Hospital, a medical corporation Seishinkai Aoshima-kai hospital.
Hot stocks summary (morning session): Nippon Yusen, Hamagomu, JTOWER, etc.
KOKUSAI <6525>: ¥4875 (+¥155), a significant rebound. Semiconductor-related stocks, including the company, are generally rising today. In the US market, there is a trend of rolling back Trump Trade, and the SOX index rose 4% the previous day. There is a dominant trend of buying on the dip for domestic-related stocks. Regarding the company, the selling price of the stock was decided to be ¥4578 the previous day, and there seems to be a trend of share buyback preceding. Furthermore, it is the start of the acquisition period for share buyback from today.
No Data